Jump To Top

groundrushairsports

COVID-19

Preventing serious complications from COVID-19 in potentially vulnerable populations in high risk environments, such as prisons, and preventing spread to surrounding communities needs a coordinated evidence-based...

People who’ve had Covid-19 are highly unlikely to contract it again for at least six months after their first infection, according to a British study of healthcare workers on the frontline of fight...

She first noticed it back in June — about three months after her earliest COVID-19 symptoms set in. "I started seeing a lot of hair coming off in my hairbrush," says Courtney Dunlop, a long-time...

With cases numbers spiking around the country, it’s not difficult to see why avoiding COVID-19 is a top concern for many people nationwide. And now, Spanish researchers have issued the results of...

The COVID-19 pandemic continues to cause significant illness and death while treatment options remain limited. St. Jude Children’s Research Hospital scientists have discovered a potential strategy...

Wednesday, November 18, 2020 Primary efficacy analysis demonstrates BNT162b2 to be 95% effective against COVID-19 beginning 28 days after the first dose;170 confirmed cases of COVID-19 were evaluated,...

We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. COVID deaths have topped 50,000 in the UK, with thousands of people...

Who will be the first to get COVID-19 vaccines? No decision has been made, but the consensus among many experts in the U.S. and globally is that health care workers should be first, said Sema Sgaier of...

Individual personality traits make people up to a third more likely to adopt guidelines aimed at preventing the spread of COVID-19, a new study has found. Researchers said the results suggested that governments...

Two independent clinical studies—one by researchers at the Center for Cell-Based Therapy (CTC) in Ribeirão Preto, state of São Paulo (Brazil), on the monoclonal antibody eculizumab, and the other...